PEAK6 Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1579 |
|
|
2018
Q1 | – | Sell |
-16,697
| Closed | -$1.43M | – | 1618 |
|
|
2017
Q4 | $1.43M | Buy |
16,697
+5,774
| +53% | +$493K | 0.01% | 323 |
|
|
2017
Q3 | $928K | Buy |
+10,923
| New | +$928K | ﹤0.01% | 401 |
|
|
2017
Q2 | – | Sell |
-5,837
| Closed | -$385K | – | 1606 |
|
|
2017
Q1 | $385K | Sell |
5,837
-18,884
| -76% | -$1.25M | ﹤0.01% | 586 |
|
|
2016
Q4 | $1.57M | Buy |
+24,721
| New | +$1.57M | 0.01% | 299 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1387 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 1347 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 1418 |
|
|
2015
Q4 | – | Sell |
-4,328
| Closed | -$231K | – | 1570 |
|
|
2015
Q3 | $231K | Buy |
+4,328
| New | +$231K | ﹤0.01% | 797 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1656 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 1572 |
|